These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 28898540)

  • 1. Compound heterozygous TRPV4 mutations in two siblings with a complex phenotype including severe intellectual disability and neuropathy.
    Thibodeau ML; Peters CH; Townsend KN; Shen Y; Hendson G; Adam S; Selby K; Macleod PM; Gershome C; Ruben P; Jones SJM; ; Friedman JM; Gibson WT; Horvath GA
    Am J Med Genet A; 2017 Nov; 173(11):3087-3092. PubMed ID: 28898540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRPV4-pathy manifesting both skeletal dysplasia and peripheral neuropathy: a report of three patients.
    Cho TJ; Matsumoto K; Fano V; Dai J; Kim OH; Chae JH; Yoo WJ; Tanaka Y; Matsui Y; Takigami I; Monges S; Zabel B; Shimizu K; Nishimura G; Lausch E; Ikegawa S
    Am J Med Genet A; 2012 Apr; 158A(4):795-802. PubMed ID: 22419508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of TRPV4-Related disorders: From skeletal dysplasia to neuromuscular phenotype.
    Ürel-Demir G; Şimşek-Kiper PÖ; Öncel İ; Utine GE; Haliloğlu G; Boduroğlu K
    Eur J Paediatr Neurol; 2021 May; 32():46-55. PubMed ID: 33774370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPV4 axonal neuropathy spectrum disorder.
    McEntagart M
    J Clin Neurosci; 2012 Jul; 19(7):927-33. PubMed ID: 22617546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRPV4 mutations causing mixed neuropathy and skeletal phenotypes result in severe gain of function.
    Taga A; Peyton MA; Goretzki B; Gallagher TQ; Ritter A; Harper A; Crawford TO; Hellmich UA; Sumner CJ; McCray BA
    Ann Clin Transl Neurol; 2022 Mar; 9(3):375-391. PubMed ID: 35170874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPV4-pathy, a novel channelopathy affecting diverse systems.
    Dai J; Cho TJ; Unger S; Lausch E; Nishimura G; Kim OH; Superti-Furga A; Ikegawa S
    J Hum Genet; 2010 Jul; 55(7):400-2. PubMed ID: 20505684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropathy-causing TRPV4 mutations disrupt TRPV4-RhoA interactions and impair neurite extension.
    McCray BA; Diehl E; Sullivan JM; Aisenberg WH; Zaccor NW; Lau AR; Rich DJ; Goretzki B; Hellmich UA; Lloyd TE; Sumner CJ
    Nat Commun; 2021 Mar; 12(1):1444. PubMed ID: 33664271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in the gene encoding the calcium-permeable ion channel TRPV4 produce spondylometaphyseal dysplasia, Kozlowski type and metatropic dysplasia.
    Krakow D; Vriens J; Camacho N; Luong P; Deixler H; Funari TL; Bacino CA; Irons MB; Holm IA; Sadler L; Okenfuss EB; Janssens A; Voets T; Rimoin DL; Lachman RS; Nilius B; Cohn DH
    Am J Hum Genet; 2009 Mar; 84(3):307-15. PubMed ID: 19232556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia family.
    Dai J; Kim OH; Cho TJ; Schmidt-Rimpler M; Tonoki H; Takikawa K; Haga N; Miyoshi K; Kitoh H; Yoo WJ; Choi IH; Song HR; Jin DK; Kim HT; Kamasaki H; Bianchi P; Grigelioniene G; Nampoothiri S; Minagawa M; Miyagawa SI; Fukao T; Marcelis C; Jansweijer MC; Hennekam RC; Bedeschi F; Mustonen A; Jiang Q; Ohashi H; Furuichi T; Unger S; Zabel B; Lausch E; Superti-Furga A; Nishimura G; Ikegawa S
    J Med Genet; 2010 Oct; 47(10):704-9. PubMed ID: 20577006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The puzzle of TRPV4 channelopathies.
    Nilius B; Voets T
    EMBO Rep; 2013 Feb; 14(2):152-63. PubMed ID: 23306656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRPV4-associated skeletal dysplasias.
    Nishimura G; Lausch E; Savarirayan R; Shiba M; Spranger J; Zabel B; Ikegawa S; Superti-Furga A; Unger S
    Am J Med Genet C Semin Med Genet; 2012 Aug; 160C(3):190-204. PubMed ID: 22791502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies.
    Zimoń M; Baets J; Auer-Grumbach M; Berciano J; Garcia A; Lopez-Laso E; Merlini L; Hilton-Jones D; McEntagart M; Crosby AH; Barisic N; Boltshauser E; Shaw CE; Landouré G; Ludlow CL; Gaudet R; Houlden H; Reilly MM; Fischbeck KH; Sumner CJ; Timmerman V; Jordanova A; Jonghe PD
    Brain; 2010 Jun; 133(Pt 6):1798-809. PubMed ID: 20460441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic spectrum and incidence of TRPV4 mutations in patients with inherited axonal neuropathy.
    Echaniz-Laguna A; Dubourg O; Carlier P; Carlier RY; Sabouraud P; Péréon Y; Chapon F; Thauvin-Robinet C; Laforêt P; Eymard B; Latour P; Stojkovic T
    Neurology; 2014 May; 82(21):1919-26. PubMed ID: 24789864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo
    Ragamin A; Gomes CC; Bindels-de Heus K; Sandoval R; Bassenden AV; Dib L; Kok F; Alves J; Mathijssen I; Medici-Van den Herik E; Eveleigh R; Gayden T; Pullens B; Berghuis A; van Slegtenhorst M; Wilke M; Jabado N; Mancini GMS; Gomez RS
    J Med Genet; 2022 Mar; 59(3):305-312. PubMed ID: 33685999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein informatics combined with multiple data sources enriches the clinical characterization of novel TRPV4 variant causing an intermediate skeletal dysplasia.
    Hines SL; Richter JE; Mohammad AN; Mahim J; Atwal PS; Caulfield TR
    Mol Genet Genomic Med; 2019 Mar; 7(3):e566. PubMed ID: 30693671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mosaicism for a lethal TRPV4 mutation results in non-lethal metatropic dysplasia.
    Weinstein MM; Kang T; Lachman RS; Bamshad M; Nickerson DA; Krakow D; Cohn DH
    Am J Med Genet A; 2016 Dec; 170(12):3298-3302. PubMed ID: 27530454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRPV4 related skeletal dysplasias: a phenotypic spectrum highlighted byclinical, radiographic, and molecular studies in 21 new families.
    Andreucci E; Aftimos S; Alcausin M; Haan E; Hunter W; Kannu P; Kerr B; McGillivray G; McKinlay Gardner RJ; Patricelli MG; Sillence D; Thompson E; Zacharin M; Zankl A; Lamandé SR; Savarirayan R
    Orphanet J Rare Dis; 2011 Jun; 6():37. PubMed ID: 21658220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
    Rock MJ; Prenen J; Funari VA; Funari TL; Merriman B; Nelson SF; Lachman RS; Wilcox WR; Reyno S; Quadrelli R; Vaglio A; Owsianik G; Janssens A; Voets T; Ikegawa S; Nagai T; Rimoin DL; Nilius B; Cohn DH
    Nat Genet; 2008 Aug; 40(8):999-1003. PubMed ID: 18587396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gain-of-function mutation in TRPV4 identified in patients with osteonecrosis of the femoral head.
    Mah W; Sonkusare SK; Wang T; Azeddine B; Pupavac M; Carrot-Zhang J; Hong K; Majewski J; Harvey EJ; Russell L; Chalk C; Rosenblatt DS; Nelson MT; Séguin C
    J Med Genet; 2016 Oct; 53(10):705-9. PubMed ID: 27330106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early-onset severe neuromuscular phenotype associated with compound heterozygosity for OPA1 mutations.
    Schaaf CP; Blazo M; Lewis RA; Tonini RE; Takei H; Wang J; Wong LJ; Scaglia F
    Mol Genet Metab; 2011 Aug; 103(4):383-7. PubMed ID: 21636302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.